SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4.
Bertrand-Chapel A, Caligaris C, Fenouil T, Savary C, Aires S, Martel S, Huchedé P, Chassot C, Chauvet V, Cardot-Ruffino V, Morel AP, Subtil F, Mohkam K, Mabrut JY, Tonon L, Viari A, Cassier P, Hervieu V, Castets M, Mauviel A, Sentis S, Bartholin L.
Bertrand-Chapel A, et al. Among authors: hervieu v.
Commun Biol. 2022 Oct 7;5(1):1068. doi: 10.1038/s42003-022-03994-6.
Commun Biol. 2022.
PMID: 36207615
Free PMC article.